Beijing Beilu Pharmaceutical Co Ltd SZSE:300016:
SAYS BIMATOPROST OPHTHALMIC SOLUTION RECEIVES NMPA'S DRUG REGISTRATION CERTIFICATE
Beijing Beilu Pharmaceutical Co Ltd SZSE:300016:
SAYS BIMATOPROST OPHTHALMIC SOLUTION RECEIVES NMPA'S DRUG REGISTRATION CERTIFICATE
Beijing Beilu Pharmaceutical Co., Ltd. on 6ix
Follow Beijing Beilu Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Beilu Pharmaceutical